Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kern

Showing results (211-220 of 472) with videos related to

Pageof 48
Sort By:
Pharmaceutical Research|August 1, 1992
Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless miceP H Lee, M H Su, E R Kern, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1976
Effect of cytosine arabinoside and 5-iodo-2'-deoxyuridine on a cytomegalovirus infection in newborn miceD K Kelsey, E R Kern, J C Overall, et al.
Arthritis and Rheumatism|December 31, 1998
Murine cytomegalovirus induces a Sjögren's syndrome-like disease in C57Bl/6-lpr/lpr miceM Fleck, E R Kern, T Zhou, et al.
Molecular Microbiology|February 13, 1999
Hemi-methylated oriC DNA binding activity found in non-specific acid phosphataseE Reshetnyak, E d'Alençon, R Kern, et al.
The Journal of Infectious Diseases|November 1, 1981
Differences in neurovirulence among isolates of Herpes simplex virus types 1 and 2 in mice using four routes of infectionJ T Richards, E R Kern, J C Overall, et al.
Vaccine|November 18, 2005
Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2Debra C Quenelle, Deborah J Collins, Dante J Marciani, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1978
Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complexE R Kern, G A Olsen, J C Overall, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1978
Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acidE R Kern, J T Richards, J C Overall, et al.
The Journal of Infectious Diseases|April 1, 1977
Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphateE R Kern, J T Richards, J C Overall, et al.
Cellular Immunology|February 1, 1977
Comparison of antiviral and antitumor activity of activated macrophagesP S Morahan, L A Glasgow, J L Crane, et al.
Pageof 48

Showing results (211-220 of 472) with videos related to

Sort By:
Pageof 48
Pharmaceutical Research|August 1, 1992
Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless miceP H Lee, M H Su, E R Kern, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1976
Effect of cytosine arabinoside and 5-iodo-2'-deoxyuridine on a cytomegalovirus infection in newborn miceD K Kelsey, E R Kern, J C Overall, et al.
Arthritis and Rheumatism|December 31, 1998
Murine cytomegalovirus induces a Sjögren's syndrome-like disease in C57Bl/6-lpr/lpr miceM Fleck, E R Kern, T Zhou, et al.
Molecular Microbiology|February 13, 1999
Hemi-methylated oriC DNA binding activity found in non-specific acid phosphataseE Reshetnyak, E d'Alençon, R Kern, et al.
The Journal of Infectious Diseases|November 1, 1981
Differences in neurovirulence among isolates of Herpes simplex virus types 1 and 2 in mice using four routes of infectionJ T Richards, E R Kern, J C Overall, et al.
Vaccine|November 18, 2005
Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2Debra C Quenelle, Deborah J Collins, Dante J Marciani, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1978
Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complexE R Kern, G A Olsen, J C Overall, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1978
Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acidE R Kern, J T Richards, J C Overall, et al.
The Journal of Infectious Diseases|April 1, 1977
Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphateE R Kern, J T Richards, J C Overall, et al.
Cellular Immunology|February 1, 1977
Comparison of antiviral and antitumor activity of activated macrophagesP S Morahan, L A Glasgow, J L Crane, et al.
Pageof 48